Citigroup’s KALA BIO KALA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-232
| Closed | -$6.45K | – | 6174 |
|
|
2025
Q4 | $6.45K | Buy |
232
+218
| +1,557% | +$9.76K | ﹤0.01% | 5177 |
|
|
2025
Q3 | $1.1K | Buy |
+14
| New | +$6.94K | ﹤0.01% | 5609 |
|
|
2025
Q1 | – | Sell |
-114
| Closed | -$39.4K | – | 5778 |
|
|
2024
Q4 | $39.4K | Buy |
114
+108
| +1,800% | +$34K | ﹤0.01% | 5141 |
|
|
2024
Q3 | $1.69K | Hold |
6
| – | – | ﹤0.01% | 5423 |
|
|
2024
Q2 | $2.1K | Hold |
6
| – | – | ﹤0.01% | 5331 |
|
|
2024
Q1 | $2.32K | Hold |
6
| – | – | ﹤0.01% | 5379 |
|
|
2023
Q4 | $2.07K | Hold |
6
| – | – | ﹤0.01% | 5413 |
|
|
2023
Q3 | $2.63K | Hold |
6
| – | – | ﹤0.01% | 4891 |
|
|
2023
Q2 | $4.32K | Hold |
6
| – | – | ﹤0.01% | 5202 |
|
|
2023
Q1 | $4.46K | Sell |
6
-4
| -40% | -$3.49K | ﹤0.01% | 4971 |
|
|
2022
Q4 | $18.1K | Buy |
10
+4
| +67% | +$1.58K | ﹤0.01% | 4633 |
|
|
2022
Q3 | $3K | Hold |
6
| – | – | ﹤0.01% | 5390 |
|
|
2022
Q2 | $5K | Sell |
6
-3
| -33% | -$4.71K | ﹤0.01% | 5617 |
|
|
2022
Q1 | $33K | Sell |
9
-3
| -25% | -$7.86K | ﹤0.01% | 4911 |
|
|
2021
Q4 | $36K | Buy |
12
+7
| +140% | +$32.5K | ﹤0.01% | 5211 |
|
|
2021
Q3 | $31K | Buy |
5
+1
| +25% | +$8.63K | ﹤0.01% | 5009 |
|
|
2021
Q2 | $47K | Sell |
4
-4
| -50% | -$62.9K | ﹤0.01% | 4858 |
|
|
2021
Q1 | $140K | Buy |
8
+3
| +60% | +$58.6K | ﹤0.01% | 4211 |
|
|
2020
Q4 | $79K | Hold |
5
| – | – | ﹤0.01% | 5723 |
|
|
2020
Q3 | $92K | Sell |
5
-170
| -97% | -$3.91M | ﹤0.01% | 5179 |
|
|
2020
Q2 | $4.59M | Buy |
175
+172
| +5,733% | +$4.87M | ﹤0.01% | 1940 |
|
|
2020
Q1 | $70K | Hold |
3
| – | – | ﹤0.01% | 5663 |
|
|
2019
Q4 | $27K | Buy |
3
+2
| +200% | +$19.3K | ﹤0.01% | 6774 |
|
|
2019
Q3 | $9K | Sell |
1
-2
| -67% | -$24.3K | ﹤0.01% | 7123 |
|
|
2019
Q2 | $42K | Buy |
3
+1
| +50% | +$16.6K | ﹤0.01% | 6625 |
|
|
2019
Q1 | $40K | Buy |
2
+1
| +100% | +$17.8K | ﹤0.01% | 6512 |
|
|
2018
Q4 | $17K | Hold |
1
| – | – | ﹤0.01% | 6953 |
|
|
2018
Q3 | $25K | Buy |
+1
| New | +$30.5K | ﹤0.01% | 6974 |
|
|
2018
Q2 | – | Sell |
-1
| Closed | -$38.4K | – | 7049 |
|
|
2018
Q1 | $51K | Hold |
1
| – | – | ﹤0.01% | 6156 |
|
|
2017
Q4 | $30K | Sell |
1
-23
| -96% | -$1.08M | ﹤0.01% | 6505 |
|
|
2017
Q3 | $1.35M | Buy |
+24
| New | +$1.32M | ﹤0.01% | 3060 |
|
Other funds holding KALA
VF
ACM
GCP
VCM
Citigroup's KALA Position: Q1 2026 in Review
Citigroup sold out of KALA BIO (KALA) in Q1 2026, closing a stake of 232 shares — an estimated $6.45K sold.
Citigroup first reported a position in KALA in Q3 2017 and held it in 31 quarters. The position peaked at $4.59M in Q2 2020. 28 funds tracked by Wall St. Rank hold KALA as of Q1 2026.
- Citigroup reported no remaining KALA BIO position as of Q1 2026 after selling out during the quarter.
- Citigroup sold 232 KALA BIO shares in Q1 2026, an estimated $6.45K.
- Citigroup first reported a position in KALA BIO in Q3 2017 and held it in 31 quarters.
- Citigroup's KALA BIO position peaked at $4.59M in Q2 2020.
- 28 funds tracked by Wall St. Rank held KALA BIO as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.